Table 2

Summary of the effects of home-based versus centre-based cardiac rehabilitation

Heterogeneity
Outcome or subgroupNumber of studiesNumber of participantsSummary estimate and modelEffect estimate (95% CI) with p values where significantχ2d.f.p ValueI2 (%)
Exercise capacity
 ≤12-month follow-up191876Standard mean difference, random-effects model−0.10 (−0.29 to 0.08)63.3018<0.0000172
 12–24-month follow-up31074Standard mean difference, fixed-effects model0.11 (−0.01 to 0.23)0.9720.620
Blood pressure (mm Hg) at 3–12-month follow-up
 Systolic91117Mean difference, random-effects model0.19 (−3.37 to 3.75)23.0780.00365
 Diastolic8991Mean difference, fixed-effects model−1.86 (−2.95 to −0.76) lower in centre-based group (p=0.009)11.1270.1337
Cholesterol (mmol/L) at 3–12-month follow-up
 Total91109Mean difference, random-effects model−0.07 (−0.24 to 0.11)20.9880.00762
 HDL7883Mean difference, fixed-effects model−0.07 (−0.11 to −0.03) lower in centre-based group (p=0.001)10.4960.1143
 LDL5388Mean difference, random-effects model−0.06 (−0.27 to 0.15)10.6040.0362
 Triglycerides5354Mean difference, random-effects model−0.16 (−0.38 to 0.07)7.5940.1147
Smoking (3–12 months)6986Relative risk, fixed-effects model0.98 (0.79 to 1.21)4.4850.480
Completers181984Risk ratio, fixed-effects model1.04 (1.01 to 1.07)
higher completion in home-based group (p=0.009)
30.26170.0244
Mortality71166Relative risk, fixed-effects model0.79 (0.43 to 1.47)1.6050.900
  • HDL, high-density lipoprotein; LDL, low-density lipoprotein.